Sentinel lymph node biopsy in melanoma

Journal of Nuclear Medicine

Volumn 47, Issue 2, 2006, Pages 191-195

  Uren, Roger F ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCURACY; ADJUVANT THERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; ECHOGRAPHY; GENETIC TRAIT; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MEDICAL EDUCATION; MELANOMA; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN SURGERY; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; NOTE; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SKIN TUMOR;

HUMANS; LYMPHATIC METASTASIS; MELANOMA; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 33745068889     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
2. Braithwaite LR. The flow of lymph from the ileocaecal angle, and its possible bearing on the cause of duodenal and gastric ulcer. Br J Surg. 1923;11:7-26.
3. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer. 1960;13:77-78.
4. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-466.
5. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131-149.
6. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
7. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med. 1996;37:964-966.
8. Uren RF, Howman-Giles R, Thompson JF. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol. 1998;5:384-387.
9. Uren RF, Howman-Giles R, Thompson JF, et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 2000;135:1168-1172.
10. McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543-547.
11. Reintgen DS, Cox EB, McCarty KS Jr, Volmer RT, Seigler HF. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg. 1983;198:379-385.
12. McCarthy W, Shaw H, Milton G. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. Surg Gynecol Obstet. 1985;161:575-580.
13. Rossi CR, De Salvo GL, Trifirò G, et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian multicentric study (SOLISM-IMI). J Nucl Med. 2006;47:234-241.
14. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg. 1994;220:759-767.
15. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-260.
16. Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol. 1993;2:303-308.
17. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med. 1993;34:1435-1440.
18. Cochran AJ. The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med. 2000;30:11-17.
19. Kammula US, Ghossein R, Bhattacharya S, et al. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients. J Clin Oncol. 2004;22:3989-3996.
20. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462-468.
21. Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999;65:500-505.
22. Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg. 2002;89:1032-1034.
23. Estourgie SH, Nieweg OE, Kroon BB. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg. 2004;91:1370-1371.
24. van Poll D, Thompson JF, Colman MH, et al. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Ann Surg Oncol. 2005;12:597-608.
25. Pawlik TM, Ross MI, Thompson JF, et al. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol. 2005;23:4588-4590.
26. Kang JC, Wanek LA, Essner R, et al. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma. J Clin Oncol. 2005;23:4764-4770.
27. Morton DL, Thompson JF, Cochran AJ, et al. Interim results of the multicenter selective lymphadenectomy trial (MSLT-I) in clinical stage I melanoma [abstract]. J Clin Oncol. 2005;23(16 suppl):710.
28. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302-311.
29. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. - WHO Melanoma Programme. Lancet. 1998;351:793-796.
30. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536-540.
31. Tsao H, Sober AJ. Melanoma treatment update. Dermatol Clin. 2005;23:323-333.
32. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976-983.
33. McMasters KM, Sondak V, Lotze M, et al. Recent advances in melanoma staging and therapy. Ann Surg Oncol. 1999;6:467-475.
34. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634.
35. Ferrone CR, Panageas KS, Busam K, et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol. 2002;9:637-645.
36. Zettersten E, Shaikh L, Ramirez R, et al. Prognostic factors in primary cutaneous melanoma. Surg Clin North Am. 2003;83:61-75.
37. Gershenwald JE, Bar-Eli M. Gene expression profiling of human cutaneous melanoma: are we there yet? Cancer Biol Ther. 2004;3:121-123.
38. Thompson JF, Saw RP, Colman MH, Howman-Giles RB, Uren RF. Contralateral groin node metastasis from lower limb melanoma. Eur J Cancer. 1997;33:976-977.
39. Jonk A, Kroon BB, Mooi WJ, Hoefnagel CA. Contralateral inguinal lymph node metastasis in patients with melanomas of the lower extremites. Br J Surg. 1989;76:1161-1162.
40. Thompson JF, Uren RF, Saw RP, Stevens GN. Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest. ANZ J Surg. 2005;75:723-725.
41. Bafounta ML, Beauchet A, Chagnon S, Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol. 2004;5:673-680.
42. Blum A, Schlagenhauff B, Stroebel W, et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer. 2000;88:2534-2539.
43. Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol. 2003;83:80-84.
44. Starritt EC, Uren RF, Scolyer RA, Quinn MJ, Thompson JF. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol. 2005;12:18-23.